[1]
Klotz, L. et al. 2018. Supplementary data: Testosterone suppression in the treatment of recurrent or metastatic prostate cancer – A Canadian consensus statement. Canadian Urological Association Journal. 12, 2 (Feb. 2018), E45–6. DOI:https://doi.org/10.5489/cuaj.5206.